Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App





New COVID-19 Vaccination Strategy Suggests Targeting Potential Superspreaders First

By HospiMedica International staff writers
Posted on 16 Nov 2020
Researchers have unveiled a COVID-19 vaccination strategy addressing the question of who should be vaccinated first and have suggested focusing on the locations a potential superspreader visits as well as vaccinating all contacts.

With thousands of scientists around the world racing to develop a vaccine for COVID-19, policy makers may need to decide who is at the front of the vaccination queue if initial supplies are limited. More...
Researchers at Macquarie University (Sydney, Australia) may have a solution once a COVID-19 vaccine is ready. The researchers have developed a theoretical model for a new vaccination strategy that would have the biggest impact - with the least amount of resources - on suppressing the spread of the coronavirus by identifying locations visited by people who are most likely to become so-called superspreaders, and vaccinating them. A superspreader is someone who transmits an infectious disease to an unexpectedly large number of other people.

The research team used anonymized location data for the pre-pandemic movements of 600,000 people in Shanghai and Beijing who were on a messaging app called Momo. The team analyzed a staggering 56 million location visits in just 71 days. The researchers then calculated all the other people the superspreaders would have come in direct and indirect contact with and then extrapolated these trends to develop a model to test the theoretical effectiveness of a vaccine strategy.

Using the location data, they ranked people into six classes by the number of places they’d visited - the higher the number the more contacts. For example, Class 1 meant the person had only stayed at home or visited local shops and been in contact with up to five people. A person in Class 2 would have also gone to a coffee shop or a bus stop and been in direct and indirect contact with up to 15 people. A Class 3 person would have gone to a local train station or the office, a small park or a swimming pool and been in close proximity to up to 25 people, whereas a Class 6 person had visited highly populated public places like universities, airports and stadiums and potentially been in direct and indirect contact with more than a hundred people. The Class 6 people are clearly more likely to become superspreaders.

If this vaccine strategy is to be put into practice once a COVID-19 vaccine is ready, the researchers emphasize the importance for public locations such as restaurants, cafes, clubs, shops, sporting and entertainment facilities to generate an accurate list of patrons so that they could be traced and vaccinated.

“Focusing on the locations where a potential superspreader visits and vaccinating all direct and indirect contacts in the cluster at those locations is the most effective method,” said Professor Bernard Mans, of Macquarie University's Department of Computing. “We found this approach would be as good as vaccinating identified superspreaders based on an accurate contact list and significantly better than random vaccinations.”

“Our research shows that to be effective (and realistic), it’s not about who exactly a superspreader has been in contact with 24/7 but where they’ve been that should be the focus of vaccination,” added Mans.

Related Links:
Macquarie University


Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Ureteral Dilatation Balloon
Dornier Equinox
Mammography System (Analog)
MAM VENUS
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.